Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles

Journal of Microencapsulation

Volumn 31, Issue 6, 2014, Pages 551-559

  Tu, Y S ^a   Fu, J W ^a,b   Sun, D M ^a   Zhang, J J ^a   Yao, N ^a   Huang, D E ^a   Shi, Z Q ^a  

^a Guangdong Provincial Institute of Traditional Chinese Medicine   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bioavailability; Cubosome; Curcumin; Piperine

Indexed keywords

CUBOSOME NANOPARTICLE; CURCUMIN; NANOPARTICLE; PIPERINE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; NANOCAPSULE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MASS FRAGMENTOGRAPHY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; QUANTITATIVE ANALYSIS; SUSPENSION; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; METABOLISM; SMALL ANGLE SCATTERING; SPLEEN; TISSUE CULTURE TECHNIQUE; X RAY DIFFRACTION;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZODIOXOLES; CURCUMIN; MICE; NANOCAPSULES; PARTICLE SIZE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; SCATTERING, SMALL ANGLE; SPLEEN; TISSUE CULTURE TECHNIQUES; X-RAY DIFFRACTION;

EID: 84906537558     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2014.885607     Document Type: Article

References (44)

1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol, 2007;595: 1-75
2. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm, 2007;4: 807-18
3. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol, 2010; 79: 330-8
4. Berginc K, Trontelj J, Basnet NS, Kristl A. Physiological barriers to the oral delivery of curcumin. Pharmazie, 2012;67: 518-24
5. Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav, 2009;92: 39-43
6. Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules, 2012;17: 5972-87
7. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res, 2005;22: 2163-73
8. Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y. Self-Assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Int J Pharm, 2010;396: 179-87
9. Gao ZS, Fu YX, Wang JD. Study on the preparation of curcumin inclusion complex and its stability. Zhong Yao Cai, 2011a;34: 1615-17
10. Gao ZS, Zhang XL, Wang JD. Preparation of curcumin solid dispersion and inclusion complex. Zhong Yao Cai, 2011b;34: 1784-8
11. Ghanghoria R, Kesharwani P, Agashe H, Jain NK. Transdermal delivery of cyclodextrin-solubilized curcumin. Drug Deliv Transl Res, 2012;3: 272-85
12. Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today, 2010;15: 1032-40
13. Han S, Shen JQ, Gan Y, Geng HM, Zhang XX, Zhu CL, Gan L. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharmacol Sin, 2010; 31: 990-8
14. Irving GR, Karmokar A, Berry DP, Brown K, Steward WP. Curcumin: The potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol, 2011;25: 519-34
15. Jagetia GC, Aggarwal BB. "Spicing up" of the immune system by curcumin. J Clin Immunol, 2007;27: 19-35
16. Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, Liu S, Dontu G, Wicha MS. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat, 2010;122: 777-85
17. Lai J, Lu Y, Yin Z, Hu F, Wu W. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int J Nanomedicine, 2010;5: 13-23
18. Landh T. Phase behavior in the system pine needle oil monoglyceridespoloxamer 407-water at 20.degree. J Phys Chem, 1994;98: 8453-67
19. Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, Cengel KA, Christofidou-Solomidou M. Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res, 2010;173: 590-601
20. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer, 2005;104: 1322-31
21. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther, 2011;11: 464-73
22. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcuminphospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm, 2007;330: 155-63
23. Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar DS. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimers disease. PLoS One, 2012;7: E32616
24. Metzler M, Pfeiffer E, Schulz SI, Dempe JS. Curcumin uptake and metabolism. Biofactors, 2013;39: 14-20
25. Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R. Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopy. Vibrat Spectrosc, 2012;62: 77-84
26. Moorthi C, Krishnan K, Manavalan R, Kathiresan K. Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles. Asian Pac J Trop Biomed, 2012;2: 841-8
27. Nabavi SF, Moghaddam AH, Eslami S, Nabavi SM. Protective effects of curcumin against sodium fluoride-induced toxicity in rat kidneys. Biol Trace Elem Res, 2012;145: 369-74
28. Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm, 2004;271: 281-6
29. Rachmawati H, Al Shaal L, Muller RH, Keck CM. Development of curcumin nanocrystal: Physical aspects. J Pharm Sci, 2013;102: 204-14
30. Rizwan SB, Assmus D, Boehnke A, Hanley T, Boyd BJ, Rades T, Hook S. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm, 2011;79: 15-22
31. Selvendiran K, Sakthisekaran D. Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis. Biomed Pharmacother, 2004;58: 264-7
32. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci, 2009;37: 223-30
33. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med, 1998;64: 353-6
34. Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol, 2011;11: 331-41
35. Sunagawa Y, Wada H, Suzuki H, Sasaki H, Imaizumi A, Fukuda H, HashimotoT, Katanasaka Y, Shimatsu A, Kimura T, et al. A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats. Biol Pharm Bull, 2012;35: 139-44
36. Tang H, Murphy CJ, Zhang B, Shen Y, Van Kirk EA, Murdoch WJ, Radosz M. Curcumin polymers as anticancer conjugates. Biomaterials, 2010;31: 7139-49
37. Wu SJ, Tam KW, Tsai YH, Chang CC, Chao JC. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. Am J Chin Med, 2010;38: 99-111
38. Xu DH, Wang S, Mei XT, Luo XJ, Xu SB. Studies on solubility enhancement of curcumin by Polyvinylpyrrolidione K30. Zhong Yao Cai, 2008;31: 438-42
39. Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol, 2010;80: 1021-32
40. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr, 2001;21: 381-406
41. Yang Z, Tan Y, Chen M, Dian L, Shan Z, Peng X, Wu C. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech, 2012;13: 1483-91
42. Zebib B, Mouloungui Z, Noirot V. Stabilization of curcumin by complexation with divalent cations in glycerol/water system. Bioinorg Chem Appl, 2010;2010: 292760. doi: 10.1155/2010/292760
43. Zhao XY, Zhang J, Zheng LQ, Li DH. Studies of cubosomes as a sustained drug delivery system. J Dispersion Sci Technol, 2005;25: 795-9
44. Zou P, Helson L, Maitra A, Stern ST, Ncneil SE. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm, 2013;10: 1977-87